XML 99 R33.htm IDEA: XBRL DOCUMENT v3.10.0.1
Share-Based Compensation (Tables)
 12 Months Ended
Dec. 31, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Share-Based Compensation Expense
The table below reflects the total share-based compensation expense recognized in our Consolidated Statements of Comprehensive Income for the years ended December 31, 2018, 2017 and 2016.
 
2018
 
2017
 
2016
 
 
 
Restricted
 
 
 
Restricted
 
 
 
Restricted
Income Statement Classification
Options (1)
 
Shares (2)
 
Options (1)
 
Shares (2)
 
Options (1)
 
Shares (2)
Direct cost of revenues
$
780

 
$
9,804

 
$
370

 
$
9,691

 
$
2,815

 
$
7,530

Selling, general and administrative expenses
2,027

 
8,191

 
1,207

 
4,870

 
1,085

 
8,998

Special charges
—

 
—

 
—

 
269

 
56

 
49

Total
$
2,807

 
$
17,995

 
$
1,577

 
$
14,830

 
$
3,956

 
$
16,577

 
(1) 
Includes options and cash-settled stock appreciation rights.
(2) 
Includes restricted share awards, restricted stock units, performance stock units and cash-settled restricted stock units.
Schedule of Stock Option and Grants Using Valuation Assumptions
We did not grant any options during the year ended December 31, 2018. We used the Black-Scholes option-pricing model to determine the fair value of our option grants during the years ended December 31, 2017 and 2016 using the assumptions in the following table.
 
Year Ended December 31,
Assumptions
2017
 
2016
Risk-free interest rate
1.60%
 
0.98%
Dividend yield
—%
 
—%
Expected term
3 years
 
3 years
Stock price volatility
31.94%
 
34.33%
Schedule of Stock Option Activity
A summary of our stock option activity during the year ended December 31, 2018 is presented below. The aggregate intrinsic value of stock options outstanding and exercisable, or fully vested, at December 31, 2018 in the table below represents the total pre-tax intrinsic value, which is calculated as the difference between the closing price of our common stock on the last trading day of 2018 and the exercise price, multiplied by the number of in-the-money options that would have been received by the option holders had all option holders exercised their options on December 31, 2018. The aggregate intrinsic value changes based on fluctuations in the fair market value per share of our common stock. 
 
Options
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Contractual
Term
(in Years)
 
Aggregate
Intrinsic
Value
Stock options outstanding at December 31, 2017
2,258

 
$
40.63

 
 
 
 
Stock options granted
—

 
N/A

 
 
 
 
Stock options exercised
(1,051
)
 
$
39.55

 
 
 
 
Stock options forfeited
(272
)
 
$
58.93

 
 
 
 
Stock options outstanding at December 31, 2018
935

 
$
36.50

 
5.0
 
$
28,181

Stock options exercisable at December 31, 2018
679

 
$
36.59

 
4.5
 
$
20,401
Schedule of Stock Options Outstanding and Exercisable
The following is a summary of stock options outstanding and exercisable as of December 31, 2018. 
 
Options Outstanding
 
Options Exercisable
 
 
 
Weighted Average Exercise Price
 
Weighted Average Remaining Contractual Term (in Years)
 
 
 
Weighted Average Exercise Price
Exercise Price Range
Options
 
 
 
Shares
 
$26.68-$33.95
200

 
$
31.39

 
4.7
 
124

 
$
31.38

$34.33-$36.04
193

 
$
34.74

 
5.4
 
152

 
$
34.85

$36.43-$36.89
222

 
$
36.79

 
5.7
 
179

 
$
36.81

$37.09-$40.36
245

 
$
39.27

 
5.3
 
158

 
$
38.67

$41.69-$55.99
75

 
$
44.62

 
1.4
 
66

 
$
44.88

 
935

 
 
 
 
 
679

 
 
Schedule of Unvested Restricted Share Activity
A summary of our unvested restricted share activity during the year ended December 31, 2018 is presented below.
 
Shares
 
Weighted
Average Grant
Date Fair
Value
Unvested restricted share awards outstanding at December 31, 2017
933

 
$
38.58

Restricted share awards granted
263

 
$
56.97

Restricted share awards vested
(188
)
 
$
37.11

Restricted share awards forfeited
(16
)
 
$
36.74

Unvested restricted share awards outstanding at December 31, 2018
992

 
$
43.76
Schedule of Restricted Stock Unit Activity
A summary of our restricted stock units activity during the year ended December 31, 2018 is presented below. The aggregate intrinsic value represents the total pre-tax intrinsic value based on the closing price of our common stock on the last trading day of 2018.
 
Shares
 
Weighted
Average Grant
Date Fair
Value
 
Intrinsic
Value
Restricted stock units outstanding at December 31, 2017
402

 
$
37.49

 
 
Restricted stock units granted
32

 
$
52.67

 
 
Restricted stock units released
(99
)
 
$
34.90

 
 
Restricted stock units forfeited
—

 
N/A

 
 
Restricted stock units outstanding at December 31, 2018
335

 
$
39.72

 
$
22,329
Schedule of Performance Stock Units Activity
A summary of our performance stock units activity during the year ended December 31, 2018 is presented below. The performance stock units are subject to market conditions based on the total shareholder return of the Company as compared with the total shareholder return of the Standard & Poor’s 500. The aggregate intrinsic value represents the total pre-tax intrinsic value based on the closing price of our common stock on the last trading day of 2018.
 
Shares
 
Weighted
Average Grant
Date Fair
Value
 
Intrinsic
Value
Performance stock units outstanding at December 31, 2017
252

 
$
25.71

 
 
Performance stock units granted
91

 
$
36.34

 
 
Performance stock units released
(29
)
 
$
29.11

 
 
Performance stock units forfeited
(39
)
 
$
29.11

 
 
Performance stock units outstanding at December 31, 2018
275

 
$
28.40

 
$
18,348
Schedule of Weighted-Average Grant Date Fair Value Per Share of Stock Options, Restricted Share Awards, Restricted Stock Units and Performance Stock Units Awarded
The table below reflects the weighted average grant date fair value per share of stock options, restricted share awards, restricted stock units and performance stock units awarded during the years ended December 31, 2018, 2017 and 2016. The fair value of our stock options is calculated using the Black-Scholes option-pricing model. The fair value of our restricted stock awards and restricted stock units is determined based on the closing market price per share of our common stock on the grant date. The fair value of the performance stock units reflects the market conditions as of the grant date using a Monte Carlo simulation.
 
Year Ended December 31,
 
2018
 
2017
 
2016
Weighted average fair value of grants
 
 
 
 
 
Stock options
$
—

 
$
9.56

 
$
8.41

Restricted share awards, restricted stock units and performance stock units
$
51.73

 
$
38.88

 
$
37.64